Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine hydrochloride for dyslipidemia with atherosclerosis
ChiCTR-OPN-17012942Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of berberine in dyslipidemia and atherosclerosis (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: Blood glucose, Triglycerides and 12 more. Started Jun 2017; status: recruiting.
02
Drugs
berberine
03
Conditions
dyslipidemiaatherosclerosis
Beyond the preview
Go deeper on ChiCTR-OPN-17012942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17012942.